Aristeia Capital’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,115,000
Closed -$11M 665
2022
Q3
$11M Hold
1,115,000
0.19% 150
2022
Q2
$11M Buy
1,115,000
+75,000
+7% +$737K 0.2% 141
2022
Q1
$10.2M Buy
+1,040,000
New +$10.1M 0.18% 147

Aristeia Capital's SHAC Position: Q4 2022 in Review

Aristeia Capital sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q4 2022, closing a stake of 1,115,000 shares — an estimated $11M sold.

Aristeia Capital first reported a position in SHAC in Q1 2022 and held it in 3 quarters. The position peaked at $11M in Q3 2022. 0 funds tracked by Wall St. Rank hold SHAC as of Q4 2022.

  • Aristeia Capital reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Aristeia Capital sold 1,115,000 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q4 2022, an estimated $11M.
  • Aristeia Capital first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q1 2022 and held it in 3 quarters.
  • Aristeia Capital's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $11M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q4 2022.

Based on Aristeia Capital's 13F filing for Q4 2022, filed 14 Feb 2023.